|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 2.560 USD | -2.66% |
|
-5.19% | -39.91% |
| Market Cap | 558M 496M 463M 422M 795M 53.63B 803M 5.6B 2.17B 27.41B 2.09B 2.05B 87.98B | P/E 2026 * |
-6.36x | P/E 2027 * | -5.06x |
|---|---|---|---|---|---|
| Enterprise Value | 558M 496M 463M 422M 795M 53.63B 803M 5.6B 2.17B 27.41B 2.09B 2.05B 87.98B | EV / Sales 2026 * |
22.3x | EV / Sales 2027 * | 22x |
| Free-Float |
94.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CTMX | Delayed | |
CBOE
| CTMX | Real-time | |
|
Boerse Muenchen
| 6C1 | Real-time | |
|
Tradegate
| 6C1 | Real-time | |
|
Deutsche Boerse AG
| 6C1 | Delayed | |
|
Börse Stuttgart
| 6C1 | Delayed | |
|
Berne S.E.
| 6C1 | End-of-day quote |
Last Transcript: CytomX Therapeutics, Inc.
| 1 day | -2.66% | ||
| 1 week | -5.19% | ||
| Current month | -5.88% | ||
| 1 month | -30.43% | ||
| 3 months | -32.98% | ||
| 6 months | -43.86% | ||
| Current year | -39.91% |
| 1 week | 2.55 |  | 2.82 |
| 1 month | 2.55 | | 3.66 |
| Current year | 2.55 | | 8.21 |
| 1 year | 2.55 | | 8.21 |
| 3 years | 0.4 | | 8.21 |
| 5 years | 0.4 | | 8.21 |
| 10 years | 0.4 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sean McCarthy
CEO | Chief Executive Officer | 59 | 2011-07-31 |
| Director of Finance/CFO | 42 | 2022-09-20 | |
Yu Waye Chu
CTO | Chief Tech/Sci/R&D Officer | 58 | 2023-07-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean McCarthy
CHM | Chairman | 59 | 2018-12-31 |
Matthew Young
BRD | Director/Board Member | 56 | 2015-08-31 |
James Meyers
BRD | Director/Board Member | 60 | 2018-12-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/3/26 | Free | General Counsel | 550,000 | 0.2524% | ||
| 7/24/26 | Free | Director | 118,000 | 0.0716% | ||
| 6/17/26 | Free | Director | 59,000 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.66% | -5.19% | -22.42% | +106.45% | 558M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | -0.47% | -1.05% | +45.13% | +126.33% | 39.11B | |
| Weighted average by Cap. | +0.12% | -0.85% | +56.84% | +138.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 25.03M 22.24M 20.76M 18.92M 35.68M 2.41B 36.01M 251M 97.34M 1.23B 93.98M 91.94M 3.95B | 25.34M 22.52M 21.01M 19.15M 36.12M 2.44B 36.46M 254M 98.54M 1.25B 95.14M 93.08M 4B |
| Net income | -80.42M -71.45M -66.69M -60.79M -115M -7.73B -116M -807M -313M -3.95B -302M -295M -12.68B | -109M -96.86M -90.4M -82.4M -155M -10.48B -157M -1.09B -424M -5.36B -409M -400M -17.19B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | US$2.560 | -2.66% | 2,624,132 |
| 26-10-01 | US$2.630 | -3.31% | 2,697,829 |
| 26-09-30 | US$2.720 | -1.09% | 3,220,701 |
| 26-09-29 | US$2.750 | +2.23% | 4,457,078 |
| 26-09-28 | US$2.690 | -0.37% | 2,694,059 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CTMX Stock
Select your edition
All financial news and data tailored to specific country editions
